A detailed history of Parkside Financial Bank & Trust transactions in Organon & Co. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 2,834 shares of OGN stock, worth $42,793. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,834
Previous 2,682 5.67%
Holding current value
$42,793
Previous $55,000 1.82%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$18.65 - $23.03 $2,834 - $3,500
152 Added 5.67%
2,834 $54,000
Q2 2024

Aug 05, 2024

BUY
$17.45 - $21.96 $1,727 - $2,174
99 Added 3.83%
2,682 $55,000
Q1 2024

May 01, 2024

BUY
$13.78 - $18.8 $23,177 - $31,621
1,682 Added 186.68%
2,583 $48,000
Q4 2023

Feb 01, 2024

SELL
$10.95 - $17.32 $1,927 - $3,048
-176 Reduced 16.34%
901 $12,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $3,682 - $5,276
222 Added 25.96%
1,077 $18,000
Q2 2023

Aug 15, 2023

BUY
$19.27 - $24.63 $2,967 - $3,793
154 Added 21.97%
855 $17,000
Q1 2023

May 04, 2023

SELL
$21.42 - $32.08 $2,784 - $4,170
-130 Reduced 15.64%
701 $16,000
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $1,048 - $1,287
45 Added 5.73%
831 $23,000
Q3 2022

Nov 01, 2022

SELL
$23.4 - $34.25 $4,048 - $5,925
-173 Reduced 18.04%
786 $19,000
Q2 2022

Jul 13, 2022

SELL
$31.66 - $38.9 $2,121 - $2,606
-67 Reduced 6.53%
959 $33,000
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $1,827 - $2,361
60 Added 6.21%
1,026 $36,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $3,727 - $4,826
-130 Reduced 11.86%
966 $29,000
Q3 2021

Oct 29, 2021

BUY
$28.63 - $35.64 $2,605 - $3,243
91 Added 9.05%
1,096 $36,000
Q2 2021

Aug 06, 2021

BUY
$28.45 - $38.0 $28,592 - $38,190
1,005 New
1,005 $30,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.84B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.